Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI model forecasts who returns to work after ICU

NCT ID NCT07616388

Knowledge-focused Sponsor: Hospital de Clinicas de Porto Alegre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study used artificial intelligence to predict how well people recover after a stay in the intensive care unit (ICU). Researchers looked at data from over 2,000 adults to see if a computer model could forecast who would have trouble with daily activities or return to work six months later. The goal was to create a tool that helps doctors plan better care, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,016 people

The number who actually took part.

Started

Mar 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Ten medical-surgical ICUs representing the five geopolitical regions of Brazil were selected as study sites. This study includes data from two databases with similar inclusion and exclusion criteria.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * ICU stay ≥ 72 hours * ICU stay ≥ 120 hours if the participant was admitted for elective surgery Exclusion Criteria: * No telephone contact available * Failure to establish contact * Transfer to another ICU

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Funcional status are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness postintensive care syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Funcional status Predictive learning models Return to work

Contacts and locations

Locations

  • Hospital de Clínicas de Porto Alegre, Intensive Care Nursing Department

    Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.